Zhang J - Search Results

1

Wnt3a: functions and implications in cancer.

He S, Lu Y, Liu X, Huang X, Keller ET, Qian CN, Zhang J. He S, et al. Among authors: zhang j. Chin J Cancer. 2015 Sep 14;34(12):554-62. doi: 10.1186/s40880-015-0052-4. Chin J Cancer. 2015. PMID: 26369691 Free PMC article. Review.

2

Soluble receptor activator of nuclear factor kappaB Fc diminishes prostate cancer progression in bone.

Zhang J, Dai J, Yao Z, Lu Y, Dougall W, Keller ET. Zhang J, et al. Cancer Res. 2003 Nov 15;63(22):7883-90. Cancer Res. 2003. PMID: 14633717

3

Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein.

Dai J, Kitagawa Y, Zhang J, Yao Z, Mizokami A, Cheng S, Nör J, McCauley LK, Taichman RS, Keller ET. Dai J, et al. Among authors: zhang j. Cancer Res. 2004 Feb 1;64(3):994-9. doi: 10.1158/0008-5472.can-03-1382. Cancer Res. 2004. PMID: 14871830

4

Osteoblasts induce prostate cancer proliferation and PSA expression through interleukin-6-mediated activation of the androgen receptor.

Lu Y, Zhang J, Dai J, Dehne LA, Mizokami A, Yao Z, Keller ET. Lu Y, et al. Among authors: zhang j. Clin Exp Metastasis. 2004;21(5):399-408. doi: 10.1007/s10585-005-0056-6. Clin Exp Metastasis. 2004. PMID: 15672864 Free article.

5

Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism.

Dai J, Keller J, Zhang J, Lu Y, Yao Z, Keller ET. Dai J, et al. Among authors: zhang j. Cancer Res. 2005 Sep 15;65(18):8274-85. doi: 10.1158/0008-5472.CAN-05-1891. Cancer Res. 2005. PMID: 16166304

6

Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity.

Kitagawa Y, Dai J, Zhang J, Keller JM, Nor J, Yao Z, Keller ET. Kitagawa Y, et al. Among authors: zhang j. Cancer Res. 2005 Dec 1;65(23):10921-9. doi: 10.1158/0008-5472.CAN-05-1809. Cancer Res. 2005. PMID: 16322239

7

Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice.

Wallner L, Dai J, Escara-Wilke J, Zhang J, Yao Z, Lu Y, Trikha M, Nemeth JA, Zaki MH, Keller ET. Wallner L, et al. Among authors: zhang j. Cancer Res. 2006 Mar 15;66(6):3087-95. doi: 10.1158/0008-5472.CAN-05-3447. Cancer Res. 2006. PMID: 16540658

8

Reversal of chemotherapy-induced leukopenia using granulocyte macrophage colony-stimulating factor promotes bone metastasis that can be blocked with osteoclast inhibitors.

Dai J, Lu Y, Yu C, Keller JM, Mizokami A, Zhang J, Keller ET. Dai J, et al. Among authors: zhang j. Cancer Res. 2010 Jun 15;70(12):5014-23. doi: 10.1158/0008-5472.CAN-10-0100. Epub 2010 May 25. Cancer Res. 2010. PMID: 20501834 Free PMC article.

9

Wnt and Wnt inhibitors in bone metastasis.

Sottnik JL, Hall CL, Zhang J, Keller ET. Sottnik JL, et al. Among authors: zhang j. Bonekey Rep. 2012 Jul 4;1:101. doi: 10.1038/bonekey.2012.101. eCollection 2012. Bonekey Rep. 2012. PMID: 23951488 Free PMC article.

10

SOD3 acts as a tumor suppressor in PC-3 prostate cancer cells via hydrogen peroxide accumulation.

Kim J, Mizokami A, Shin M, Izumi K, Konaka H, Kadono Y, Kitagawa Y, Keller ET, Zhang J, Namiki M. Kim J, et al. Among authors: zhang j. Anticancer Res. 2014 Jun;34(6):2821-31. Anticancer Res. 2014. PMID: 24922645

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179,312 results

Search Page

Filters